Argus

Argus


Argus Research on Interactive Brokers

To subscribe to Argus Research, log in to Client Portal, then select Menu - Settings - User Settings - Research Subscriptions (Configure Gear icon) - Current Subscriptions (Configure Gear icon)


Through Interactive Brokers and Trader WorkStation, Argus Research delivers authoritative and timely research that helps investors to quickly stay on top of stock investments and economic trends.

The Argus Research offering on Interactive Brokers includes easy-to-read and presentation-ready fundamental company Analyst Reports; our daily Market Digest, Market Update, Market Watch and Market Movers reports, which provide timely trading ideas and market or economic commentary; our weekly "Best of" report; plus our monthly Special Situations report.

The foundation of our offering is the Argus Analyst Report, produced on hundreds of key U.S. large- and mid-cap stocks. The six-point Argus fundamental approach is applied to generate Buy/Sell/Hold ratings, earning estimates and an investment thesis for all companies in our universe. Our Universe of Coverage includes companies that are most likely to be held in a portfolio as either an individual holding or as a position in a mutual fund, ETF or separate account. We expand this universe to include emerging companies in the mid- and small-cap market segments that we believe will grow into large-cap companies or that offer compelling attributes for investment or potential market-beating performance. The reports are written by our award-winning team of independent research analysts organized by industry, such as a healthcare, technology, or industrials. Independence means our ratings are not influenced by other brokerage or investment banking operations.

Argus Research Company was founded in 1934 and was one of the first firms to provide systematic, independent research and analysis on U.S. equities to the professional market. Using a top-down methodology, the Argus staff of analysts and its economist continues to offer forecasts and ratings on the U.S. economy, and objective investment research.


View Sample Report *Visit Website

Disclosures
  • * This sample research report is published by Argus Research and is being posted with permission from Argus Research. The views expressed in this article are solely those of the author and/or Argus Research and IB does not endorse or recommend any investment, trades or trading strategies discussed in the article. This material is provided for information only and is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad-based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation by IB to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

The risk of loss in online trading of stocks, options, futures, currencies, foreign equities, and fixed income can be substantial. Options are not suitable for all investors. For more information, read the "Characteristics and Risks of Standardized Options".

Your capital is at risk and your losses may exceed the value of your original investment.

Interactive Brokers (U.K.) Limited is authorised and regulated by the Financial Conduct Authority. FCA Reference Number 208159.

Interactive Brokers LLC is regulated by the US SEC and CFTC and is a member of the SIPC (www.sipc.org) compensation scheme;
products are only covered by the UK FSCS in limited circumstances.

Before trading, customers must read the relevant risk disclosure statements on our Warnings and Disclaimers page.

For a list of IBG memberships worldwide, see our exchange listings.